In isothermal calorimetry assays, VH298 bound VBC with a KD of 90 nM; in flourescence polarization assays using a HIF-1alpha peptide, VH298 bound VBC with a KD of 80 nM. Using SPR, VH298 had a Kon = 6.47 X 10^5/M*sec and a Koff = 0.065/sec.
PDB ID for probe-target interaction (3D structure):
5LLI
Structure-activity relationship:
See Galdeano et al., J. Med. Chem. 2014 (doi: 10.1021/jm5011258)
Probe Selectivity in Vitro:
In Dundee MRC-PPU Express Screen of 50 kinases, VH298 did not substantially inhibit any kinases at 50 uM. In CEREP ExpressProfile assay of 50 GPCRs and ion channels, VH298 did not bind any targets at 50 uM.
In cell validation
Potency in cells:
Not done
Potency assay (cells):
In HeLa cells, VH298 led to the concentration-dependent accumulation of HIF-1alpha (hydroxylated form) and HIF-2alpha.
Target engagement assay (cells):
In CETSA, VH298 stabilized VHL.
Probe Selectivity in Cell:
In chemoproteomic MS assays using an immobilized, linkable analogue of VH298, RBX1, CUL2, VHL, and TCEB2 were the only proteins that were reproducibly detected in a dose-dependent competition experiment.
Toxicity
Cytoxicity assay:
Yes
Notes on cytotoxicity:
In several cell types (fibroblasts, tumor cell lines and non-tumor cell lines) at 150 uM, VH298 was not cytotoxic.